These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Anticholinergic agents in asthma: chronic bronchodilator therapy, relief of acute severe asthma, reduction of chronic viral inflammation and prevention of airway remodeling. Kanazawa H Curr Opin Pulm Med; 2006 Jan; 12(1):60-7. PubMed ID: 16357581 [TBL] [Abstract][Full Text] [Related]
8. Beta2-agonist and anticholinergic drugs in the treatment of lung disease. Proskocil BJ; Fryer AD Proc Am Thorac Soc; 2005; 2(4):305-10; discussion 311-2. PubMed ID: 16267353 [TBL] [Abstract][Full Text] [Related]
9. The mode of action of anticholinergics in asthma. Gosens R; Gross N Eur Respir J; 2018 Oct; 52(4):. PubMed ID: 30115613 [TBL] [Abstract][Full Text] [Related]
10. [Pathophysiology of cholinergic nerves and treatment with anticholinergics in obstructive airways disease]. Karwat K Pneumonol Alergol Pol; 1997; 65(9-10):685-90. PubMed ID: 9489445 [No Abstract] [Full Text] [Related]
11. Function of pulmonary neuronal M(2) muscarinic receptors in stable chronic obstructive pulmonary disease. On LS; Boonyongsunchai P; Webb S; Davies L; Calverley PM; Costello RW Am J Respir Crit Care Med; 2001 May; 163(6):1320-5. PubMed ID: 11371395 [TBL] [Abstract][Full Text] [Related]
12. Muscarinic receptors on airway mesenchymal cells: novel findings for an ancient target. Meurs H; Dekkers BG; Maarsingh H; Halayko AJ; Zaagsma J; Gosens R Pulm Pharmacol Ther; 2013 Feb; 26(1):145-55. PubMed ID: 22842340 [TBL] [Abstract][Full Text] [Related]
13. Muscarinic receptor subtypes in airways. Barnes PJ Life Sci; 1993; 52(5-6):521-7. PubMed ID: 8441331 [TBL] [Abstract][Full Text] [Related]
14. [Anticholinergic drugs in the therapy of obstructive airway diseases]. Windt R Med Monatsschr Pharm; 2011 Apr; 34(4):130-7. PubMed ID: 21528530 [TBL] [Abstract][Full Text] [Related]
15. Effect of tiotropium bromide on airway remodeling in a chronic asthma model. Kang JY; Rhee CK; Kim JS; Park CK; Kim SJ; Lee SH; Yoon HK; Kwon SS; Kim YK; Lee SY Ann Allergy Asthma Immunol; 2012 Jul; 109(1):29-35. PubMed ID: 22727154 [TBL] [Abstract][Full Text] [Related]
16. Treatment of disorders characterized by reversible airway obstruction in childhood: are anti-cholinergic agents the answer? Quizon A; Colin AA; Pelosi U; Rossi GA Curr Pharm Des; 2012; 18(21):3061-85. PubMed ID: 22564300 [TBL] [Abstract][Full Text] [Related]
17. Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling. Gosens R; Bos IS; Zaagsma J; Meurs H Am J Respir Crit Care Med; 2005 May; 171(10):1096-102. PubMed ID: 15695490 [TBL] [Abstract][Full Text] [Related]
18. [Anticholinergic drugs in therapy of chronic obstructive lung disease (COPD)]. Beeh KM; Welte T; Buhl R Med Klin (Munich); 2000 Oct; 95(10):552-8. PubMed ID: 11092168 [TBL] [Abstract][Full Text] [Related]
19. [Regulation of bronchial tone in chronic obstructive pulmonary disease (COPD): role of muscarinic receptors]. Abad Santos F; Novalbos J; Gallego Sandín S; Gálvez Múgica MA An Med Interna; 2003 Apr; 20(4):201-5. PubMed ID: 12768836 [TBL] [Abstract][Full Text] [Related]
20. Changing face of β2-adrenergic and muscarinic receptor therapies in asthma. Wasilewski NV; Lougheed MD; Fisher JT Curr Opin Pharmacol; 2014 Jun; 16():148-56. PubMed ID: 24922602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]